Usage Examples
- The Class II infusion pump needed a 510(k) plus evidence against the special controls in its classification regulation.
- We changed the sensor supplier, so the Class II clearance no longer covers the device as built.
- That product code is Class II but 510(k)-exempt, so registration and listing are the whole premarket path.
What is Class II Medical Device?
Class II medical devices are the FDA device class subject to special controls, the additional device-type-specific requirements necessary to reasonably assure safety and effectiveness for a generic device type, beyond the general controls every device must meet.
Class II medical devices exist because FDA sorts devices by how much control is needed to trust them, not by one universal standard. Class I devices are subject only to general controls. Class III devices require premarket approval under section 515 of the FD&C Act. Class II devices sit between the two: general controls still apply, and FDA layers on controls written for that specific device type.
Class II devices cover the generic device types for which special controls are, or eventually will be, established. The class attaches to the generic type through FDA's classification regulation and product code, not to a sponsor's internal risk rating. Class II status does not remove any general control, and it does not extend to devices whose classification regulation puts them in class III under premarket approval.
Class II devices are worked in practice through two documents. The first is the classification regulation naming the product code and its special controls. The second is the premarket notification, which 21 CFR 807.81(a) requires at least 90 days before commercial distribution when the device meets the criteria there. Class II teams re-run both analyses whenever the marketed device changes.
Not to be confused with
- Class I device
- Class I is subject only to the general controls under FD&C Act sections 501, 502, 510, 516, 518, 519, and 520. Class II carries those same general controls plus a device-type-specific layer; the difference is the extra layer, not the presence of regulation.
- Class III device
- Class III is defined by the need for premarket approval under section 515. Class II reaches the market through premarket notification and a substantial-equivalence comparison to a predicate, a different submission with a different evidentiary bar.
- 510(k)
- the 510(k) is a submission; Class II is a classification. A device is Class II because of its classification regulation, while the 510(k) obligation is triggered separately by the criteria in 21 CFR 807.81(a), and some Class II product codes are exempt from it.
- Special controls
- special controls are the requirements, not the class. They are defined as the controls necessary to provide reasonable assurance of safety and effectiveness for a class II generic type, so they vary by product code rather than applying uniformly across Class II.
Class II obligations come from the device's own classification regulation plus the premarket notification rules. These are the anchors.
What you must do
- 1Confirm the device's generic type and product code in FDA's classification regulations, because class II status is what makes special controls apply at all21 CFR 860.3
- 2Meet the special controls established for that generic type, which are the controls necessary to provide reasonable assurance of safety and effectiveness for a class II device type21 CFR 860.3 (special controls)
- 3Satisfy the general controls that apply to every device regardless of class, including registration, misbranding and adulteration, records and reports, and notification provisions21 CFR 860.3 (general controls)
- 4Submit a premarket notification at least 90 days before introducing the device into interstate commerce for commercial distribution when the device meets the criteria in the rule21 CFR 807.81
- 5File a new premarket notification before a device already in commercial distribution is significantly changed or modified in design, components, method of manufacture, or intended use21 CFR 807.81(a)(3)
Common mistakes
Reading the 90 days as FDA's review clock
21 CFR 807.81 sets a filing lead time: the submission goes in at least 90 days before commercial distribution. It says nothing about how long FDA takes to respond, so launch dates built on a 90-day clearance assumption slip and pull manufacturing and marketing spend forward of a market authorisation that does not exist yet.
Classifying the device yourself instead of finding the product code
the class follows the generic device type in FDA's classification regulation. Deciding a device is Class II because it feels moderate-risk produces the wrong submission path, the wrong evidence package, and a filing that fails on the first administrative review.
Treating clearance as permanent across design changes
21 CFR 807.81(a)(3) pulls a marketed device back into premarket notification when it is about to be significantly changed or modified in design, components, method of manufacture, or intended use. Teams that switch a component supplier or rework the intended-use statement and ship first are distributing a device the existing clearance no longer describes.
When This Matters
- The Class II infusion pump needed a 510(k) plus evidence against the special controls in its classification regulation.
- We changed the sensor supplier, so the Class II clearance no longer covers the device as built.
- That product code is Class II but 510(k)-exempt, so registration and listing are the whole premarket path.
Frequently Asked Questions
Special controls are the controls necessary to provide reasonable assurance of safety and effectiveness for a generic type of device that is class II. They are device-type-specific, set out in the classification regulation for the product code, and they sit on top of the general controls that apply to every device.
Related Use Cases
- Medical Devices Use Cases
Prepare 510(k), PMA, and De Novo submissions with AI-guided pathway selection
- Consulting Use Cases
Manage 15+ client programs from one dashboard with per-client workspaces and tracking
- Regulatory Affairs Workflows
Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
- Quality/QA Workflows
Track GxP regulation changes and enforcement trends
